TRex Bio logo

TRex Bio Funding & Investors

South San Francisco, CA

TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.

trex.bio

Total Amount Raised: $169,000,000

TRex Bio Funding Rounds

  • Series B

    $84,000,000

    Series B Investors

    Delos Capital
    Avego Bioscience Capital
    Agent Capital
    Polaris Partners
    SV Health Investors
    Eli Lilly & Company Foundation
    Pfizer Venture Investments
    Alexandria Real Estate Equities
    Johnson & Johnson Innovation

  • Series A

    $26,000,000

    Series A Investors

    Polaris Partners
    SV Health Investors
    Eli Lilly & Company Foundation
    Alexandria Real Estate Equities
    Pfizer Venture Investments
    Laurion Capital Management
    Johnson & Johnson Innovation

  • Series A

    $59,000,000

    Series A Investors

    Alexandria Real Estate Equities
    Johnson & Johnson Robotics and Digital Solutions
    SV Health Investors
    Pfizer Venture Investments
    Eli Lilly and Company
Funding info provided by Diffbot.